Archives for February 10, 2015

Juno Therapeutics adds new biomanufacturing facility in Washington, will continue using CMOs

Cell-based cancer immunotherapy company Juno Therapeutics has entered into a lease agreement for a manufacturing facility in Bothell, Washington to produce its developing cell therapies.

update: WHO says tech like Nanopatch can help get vaccines to the people that need them

Vaxxas raises $20m for nanopatch vaccine trials

Vaccine patch firm Vaxxas has raised $20m (€17.7m) to fund clinical development of its pipeline of influenza, polio and bacterial infection vaccines.

Boehringer and VTU extend yeast-based expression system tech deal

Boehringer-Ingelheim has renewed its collaboration with VTU technology to develop a yeast-based protein expression system for biopharmaceutical production.

EMA defends Humira redactions, says only commercial info was blacked out

The EMA has defended its decision to redact three Humira clinical study reports, arguing that the information held back was ‘commercially confidential.’